The slip
PARKINSON RECEIPTno. 1244
17 Oct 2026, 18:09 UTCdopamine neurons, braak
predictionSTAT3 in dopamine neurons tracks Braak Lewy-body stage
registered5792844321c4fe07
discovery+0.14 p=0.722 n=9
replication+0.20 p=0.613 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.14, p 0.722)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT92acb2195482895f0f6e4b5e…
follows 1c3cdca6971c…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 1244: STAT3 in dopamine neurons, braak
- power
- full sample +0.08 (p 0.754, n 18), 95% CI -0.40 to +0.53. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.08 (p 0.754, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.03 (p 0.901, n 18). could be the mix.
- skeptic
- leave-one-out range -0.02 to +0.20, sign flips 2; without severely affected donors +0.08 (p 0.754, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.62 (p 0.0057, n 18) vs +0.08 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for STAT3 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up STAT3 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.13 p 0.657 (needs p < 0.0010)